The need of a neonatal preparation for Chagas disease

Autores
Sosa-Estani, Sergio; Belizán, José M.; Althabe, Fernando; Rubinstein, Aldofo
Año de publicación
2005
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Fil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias; Argentina.
Fil: Belizan, Jose M. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.
Fil: Althabe, Fernando. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.
Fil: Rubinstein, Aldofo. Institute for Clinical Effectiveness and Health Policy, Buenos Aires; Argentina.
We have read about the efforts and initiatives related to the design of drugs for parasitic diseases in McKerrow's article [1] with interest and expectation. One of the pressing needs in this area is for a neonatal preparation for Chagas disease. Satisfactory achievements have been made in Argentina in relation to the transmission of the disease by vectors and through blood transfusion [2,3]. Vertical transmission is now the great challenge in eradicating Chagas disease. Around 800–1,300 neonates infected with Trypanosmoma cruzi are born every year in our country [4]. Almost 99% of all births occur in hospital, thus allowing the detection of infants born with parasites immediately after birth. The initiation of treatment of these neonates before they and their mothers leave the hospital is a good strategy to obtain high treatment coverage. The later attendance of mothers with their children to health-care facilities is quite unpredictable and irregular. Also, it is difficult to link information about maternal and neonatal parasitic status obtained at birth with later attendance at other health-care facilities.
Fuente
PLoS medicine 2005; 2(11):e387.
Materia
Recién Nacido
Enfermedad de Chagas
Nivel de accesibilidad
acceso abierto
Condiciones de uso
Repositorio
Sistema de Gestión del Conocimiento ANLIS MALBRÁN
Institución
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
OAI Identificador
oai:sgc.anlis.gob.ar:Publications/123456789/2153

id SGCANLIS_8b2ee880df098d131a70abd358ee7477
oai_identifier_str oai:sgc.anlis.gob.ar:Publications/123456789/2153
network_acronym_str SGCANLIS
repository_id_str a
network_name_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
spelling The need of a neonatal preparation for Chagas diseaseSosa-Estani, SergioBelizán, José M.Althabe, FernandoRubinstein, AldofoRecién NacidoEnfermedad de ChagasFil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias; Argentina.Fil: Belizan, Jose M. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.Fil: Althabe, Fernando. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.Fil: Rubinstein, Aldofo. Institute for Clinical Effectiveness and Health Policy, Buenos Aires; Argentina.We have read about the efforts and initiatives related to the design of drugs for parasitic diseases in McKerrow's article [1] with interest and expectation. One of the pressing needs in this area is for a neonatal preparation for Chagas disease. Satisfactory achievements have been made in Argentina in relation to the transmission of the disease by vectors and through blood transfusion [2,3]. Vertical transmission is now the great challenge in eradicating Chagas disease. Around 800–1,300 neonates infected with Trypanosmoma cruzi are born every year in our country [4]. Almost 99% of all births occur in hospital, thus allowing the detection of infants born with parasites immediately after birth. The initiation of treatment of these neonates before they and their mothers leave the hospital is a good strategy to obtain high treatment coverage. The later attendance of mothers with their children to health-care facilities is quite unpredictable and irregular. Also, it is difficult to link information about maternal and neonatal parasitic status obtained at birth with later attendance at other health-care facilities.Yes2005-11info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf1549-1676https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297548/pdf/pmed.0020387.pdfhttp://sgc.anlis.gob.ar/handle/123456789/215310.1371/journal.pmed.0020387PLoS medicine 2005; 2(11):e387.reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISPLoS medicineenginfo:eu-repo/semantics/openAccess2025-09-29T14:30:39Zoai:sgc.anlis.gob.ar:Publications/123456789/2153Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-09-29 14:30:40.213Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false
dc.title.none.fl_str_mv The need of a neonatal preparation for Chagas disease
title The need of a neonatal preparation for Chagas disease
spellingShingle The need of a neonatal preparation for Chagas disease
Sosa-Estani, Sergio
Recién Nacido
Enfermedad de Chagas
title_short The need of a neonatal preparation for Chagas disease
title_full The need of a neonatal preparation for Chagas disease
title_fullStr The need of a neonatal preparation for Chagas disease
title_full_unstemmed The need of a neonatal preparation for Chagas disease
title_sort The need of a neonatal preparation for Chagas disease
dc.creator.none.fl_str_mv Sosa-Estani, Sergio
Belizán, José M.
Althabe, Fernando
Rubinstein, Aldofo
author Sosa-Estani, Sergio
author_facet Sosa-Estani, Sergio
Belizán, José M.
Althabe, Fernando
Rubinstein, Aldofo
author_role author
author2 Belizán, José M.
Althabe, Fernando
Rubinstein, Aldofo
author2_role author
author
author
dc.subject.none.fl_str_mv Recién Nacido
Enfermedad de Chagas
topic Recién Nacido
Enfermedad de Chagas
dc.description.none.fl_txt_mv Fil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias; Argentina.
Fil: Belizan, Jose M. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.
Fil: Althabe, Fernando. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.
Fil: Rubinstein, Aldofo. Institute for Clinical Effectiveness and Health Policy, Buenos Aires; Argentina.
We have read about the efforts and initiatives related to the design of drugs for parasitic diseases in McKerrow's article [1] with interest and expectation. One of the pressing needs in this area is for a neonatal preparation for Chagas disease. Satisfactory achievements have been made in Argentina in relation to the transmission of the disease by vectors and through blood transfusion [2,3]. Vertical transmission is now the great challenge in eradicating Chagas disease. Around 800–1,300 neonates infected with Trypanosmoma cruzi are born every year in our country [4]. Almost 99% of all births occur in hospital, thus allowing the detection of infants born with parasites immediately after birth. The initiation of treatment of these neonates before they and their mothers leave the hospital is a good strategy to obtain high treatment coverage. The later attendance of mothers with their children to health-care facilities is quite unpredictable and irregular. Also, it is difficult to link information about maternal and neonatal parasitic status obtained at birth with later attendance at other health-care facilities.
description Fil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias; Argentina.
publishDate 2005
dc.date.none.fl_str_mv 2005-11
dc.type.none.fl_str_mv info:ar-repo/semantics/articulo
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv 1549-1676
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297548/pdf/pmed.0020387.pdf
http://sgc.anlis.gob.ar/handle/123456789/2153
10.1371/journal.pmed.0020387
identifier_str_mv 1549-1676
10.1371/journal.pmed.0020387
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297548/pdf/pmed.0020387.pdf
http://sgc.anlis.gob.ar/handle/123456789/2153
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv PLoS medicine
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Yes
publisher.none.fl_str_mv Yes
dc.source.none.fl_str_mv PLoS medicine 2005; 2(11):e387.
reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron:ANLIS
reponame_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
collection Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname_str Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron_str ANLIS
institution ANLIS
repository.name.fl_str_mv Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
repository.mail.fl_str_mv biblioteca@anlis.gov.ar
_version_ 1844621859227697152
score 12.559606